Fact sheet - Articles - Page 34

Clinical Guidance

How to Use Sublocade and Brixadi

January 1, 2025

Noah Capurso, MD, MHS, Talia Puzantian, PharmD, BCPP, and Daniel Carlat, MD

Dr. Capurso, Dr. Puzantian, and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Sublocade and Brixadi are long-acting forms of injectable buprenorphine given once every four or eight weeks for Sublocade and weekly or monthly for Brixadi.

Clinical Guidance

Pain Management for Patients With Opioid Use Disorder

January 1, 2025

Noah Capurso, MD, MHS, Talia Puzantian, PharmD, BCPP, and Daniel Carlat, MD

Dr. Capurso, Dr. Puzantian, and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Pain and opioid use disorder (OUD) are tightly intertwined and highly comorbid.

Clinical Guidance

Managing Opioid Withdrawal in the Inpatient Setting

January 1, 2025

Noah Capurso, MD, MHS, Talia Puzantian, PharmD, BCPP, and Daniel Carlat, MD

Dr. Capurso, Dr. Puzantian, and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Who Is Likely to Experience Withdrawal Symptoms?

Clinical Guidance

How to Manage Methadone

January 1, 2025

Noah Capurso, MD, MHS, Talia Puzantian, PharmD, BCPP, and Daniel Carlat, MD

Dr. Capurso, Dr. Puzantian, and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Unless you work in a federally funded methadone clinic, known as an opioid treatment program (OTP), you won’t be managing methadone long term or making dose adjustments on your own.

Clinical Guidance

Perioperative Management of Patients on Medications for Opioid Use Disorder

January 1, 2025

Noah Capurso, MD, MHS, Talia Puzantian, PharmD, BCPP, and Daniel Carlat, MD

Dr. Capurso, Dr. Puzantian, and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Medications for opioid use disorder (MOUD) can complicate pain control during and after surgery.

Clinical Guidance

Example of a Modified Finnegan Neonatal Abstinence Score

January 1, 2025

Noah Capurso, MD, MHS, Talia Puzantian, PharmD, BCPP, and Daniel Carlat, MD

Dr. Capurso, Dr. Puzantian, and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Example of a Modified Finnegan Neonatal Abstinence Score

Clinical Guidance

How to Manage and Taper Buprenorphine

January 1, 2025

Noah Capurso, MD, MHS, Talia Puzantian, PharmD, BCPP, and Daniel Carlat, MD

Dr. Capurso, Dr. Puzantian, and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

After you have initiated buprenorphine, see patients weekly at first to make sure the dose is right.

Clinical Guidance

How to Discuss and Initiate Extended-Release Naltrexone (Vivitrol)

January 1, 2025

Noah Capurso, MD, MHS, Talia Puzantian, PharmD, BCPP, and Daniel Carlat, MD

Dr. Capurso, Dr. Puzantian, and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Extended-release naltrexone injection (XR-NTX) is an effective medication for some patients with opioid use disorder (OUD).

Clinical Guidance

How to Discuss and Initiate Buprenorphine

January 1, 2025

Noah Capurso, MD, MHS, Talia Puzantian, PharmD, BCPP, and Daniel Carlat, MD

Dr. Capurso, Dr. Puzantian, and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Induction refers to the process of starting a patient on buprenorphine (with or without naloxone; the combination product is most often preferred).

Clinical Guidance

How to Choose the Right Medications for Opioid Use Disorder

January 1, 2025

Noah Capurso, MD, MHS, Talia Puzantian, PharmD, BCPP, and Daniel Carlat, MD

Dr. Capurso, Dr. Puzantian, and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

The purpose of this fact sheet is not to provide details on pharmacology or the use of these medications, but rather to help you decide which might be best for a given patient.